{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T12:09:19Z","timestamp":1789214959778,"version":"build-2803163510"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:00:00Z","timestamp":1789171200000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100032745","name":"Gilead Sciences Italia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100032745","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"DOI":"10.1186\/s40360-026-01189-x","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T12:15:28Z","timestamp":1785759328000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Liposomal amphotericin B as an antifungal prophylaxis in bilateral lung transplantation: a safety analysis"],"prefix":"10.1186","volume":"27","author":[{"given":"Annalisa","family":"Boscolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u00f2","family":"Sella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Congedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Paiusco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Pistollato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Zanaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Chiapperini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Zarantonello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Mormando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Pagliarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"De Cassai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Pettenuzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Dell\u2019Amore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Navalesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,3]]},"reference":[{"issue":"1","key":"1189_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1288-3336(18)41298-8","volume":"2","author":"L Gust","year":"2018","unstructured":"Gust L, Trousse D, Brioude G, Doddoli C, D\u2019Journo XB. Tecniche di trapianto bipolmonare. EMC Tecniche Chirurgiche Torace. 2018;2(1):1\u201316.","journal-title":"EMC Tecniche Chirurgiche Torace"},{"issue":"10","key":"1189_CR2","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.healun.2014.08.004","volume":"33","author":"RD Yusen","year":"2014","unstructured":"Yusen RD, Edwards LB, Kucheryavaya AY, Benden C, Dipchand AI, Dobbels F, et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-first Adult Lung and Heart\u2013Lung Transplant Report\u20142014; Focus Theme: Retransplantation. J Heart Lung Transplantation. 2014;33(10):1009\u201324.","journal-title":"J Heart Lung Transplantation"},{"key":"1189_CR3","unstructured":"United Network for Organ Sharing website. Available from: https:\/\/www.unos.org\/data; [accessed 09.25]."},{"issue":"10","key":"1189_CR4","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.healun.2016.08.021","volume":"35","author":"J Stehlik","year":"2016","unstructured":"Stehlik J, Bavaria JE, Bax J, Cronenwett JL, Edwards LB, Fairman RM, et al. Heart, lung, and vascular registries: Evolving goals, successful approaches, and ongoing innovation. J Heart Lung Transplantation. 2016;35(10):1149\u201357.","journal-title":"J Heart Lung Transplantation"},{"issue":"5","key":"1189_CR5","doi-asserted-by":"publisher","first-page":"639","DOI":"10.2217\/fmb.12.28","volume":"7","author":"S Shoham","year":"2012","unstructured":"Shoham S, Marr KA. Invasive Fungal Infections in Solid Organ Transplant Recipients. Future Microbiol. 2012;7(5):639\u201355.","journal-title":"Future Microbiol"},{"issue":"2","key":"1189_CR6","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.trre.2018.12.001","volume":"33","author":"V Kabir","year":"2019","unstructured":"Kabir V, Maertens J, Kuypers D. Fungal infections in solid organ transplantation: An update on diagnosis and treatment. Transplantation Reviews. 2019;33(2):77\u201386.","journal-title":"Transplantation Reviews"},{"issue":"6","key":"1189_CR7","doi-asserted-by":"publisher","first-page":"414","DOI":"10.21037\/atm.2020.03.102","volume":"8","author":"APC Villalobos","year":"2020","unstructured":"Villalobos APC, Husain S. Infection prophylaxis and management of fungal infections in lung transplant. Ann Transl Med. 2020;8(6):414\u2013414.","journal-title":"Ann Transl Med"},{"issue":"8","key":"1189_CR8","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.jiac.2024.02.010","volume":"30","author":"K Umemura","year":"2024","unstructured":"Umemura K, Katada Y, Nakagawa S, Hira D, Yutaka Y, Tanaka S, et al. Comparison of the safety and cost-effectiveness of nebulized liposomal amphotericin B and amphotericin B deoxycholate for antifungal prophylaxis after lung transplantation. J Infect Chemother. 2024;30(8):741\u20135.","journal-title":"J Infect Chemother"},{"issue":"12","key":"1189_CR9","first-page":"2538","volume":"105","author":"W De Mol","year":"2021","unstructured":"De Mol W, Bos S, Beeckmans H, Lagrou K, Spriet I, Verleden GM, et al. Antifungal Prophylaxis After Lung Transplantation: Where Are We Now? Transplantation. 2021;105(12):2538\u201345.","journal-title":"Antifungal Prophylaxis After Lung Transplantation: Where Are We Now? Transplantation"},{"issue":"5","key":"1189_CR10","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1177\/10781552241241317","volume":"30","author":"F Javandoust Gharehbagh","year":"2024","unstructured":"Javandoust Gharehbagh F, Roshanzamiri S, Farjami M, Hatami F, Lotfollahi L, Kazeminia N, et al. Liposomal amphotericin for secondary prophylaxis: A systematic review and meta-analysis. J Oncol Pharm Pract. 2024;30(5):919\u201329.","journal-title":"J Oncol Pharm Pract"},{"key":"1189_CR11","doi-asserted-by":"publisher","unstructured":"Botero Aguirre JP, Restrepo Hamid AM. Amphotericin B deoxycholate versus liposomal amphotericin B: effects on kidney function. Cochrane Kidney and Transplant Group, curatore. Cochrane Database of Systematic Reviews. 2015;(11):CD010481. https:\/\/doi.org\/10.1002\/14651858.CD010481.pub2.","DOI":"10.1002\/14651858.CD010481.pub2"},{"issue":"11","key":"1189_CR12","doi-asserted-by":"publisher","first-page":"5392","DOI":"10.1021\/acs.molpharmaceut.4c00485","volume":"21","author":"SK Dash","year":"2024","unstructured":"Dash SK, Benival D, Jindal AB. Formulation Strategies to Overcome Amphotericin B Induced Toxicity. Mol Pharm. 2024;21(11):5392\u2013412.","journal-title":"Mol Pharm"},{"issue":"1","key":"1189_CR13","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s40121-024-01086-y","volume":"14","author":"F Bridi Cavassin","year":"2025","unstructured":"Bridi Cavassin F, Magri MMC, Borgmann AV, Floriani ID, Barreto MR, Zaleski T, et al. Acute Infusion-Related Side Effects of Amphotericin B Lipid Complex (ABLC) in Oncohematological Patients: Real-World Data from Brazilian Reference Centers. Infect Dis Ther. 2025;14(1):133\u201348.","journal-title":"Infect Dis Ther"},{"issue":"1","key":"1189_CR14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s13181-010-0120-8","volume":"7","author":"GP Patel","year":"2011","unstructured":"Patel GP, Crank CW, Leikin JB. An Evaluation of Hepatotoxicity and Nephrotoxicity of Liposomal Amphotericin B (L-AMB). J Med Toxicol. 2011;7(1):12\u20135.","journal-title":"J Med Toxicol"},{"issue":"5","key":"1189_CR15","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.ijantimicag.2011.07.004","volume":"38","author":"A Shigemi","year":"2011","unstructured":"Shigemi A, Matsumoto K, Ikawa K, Yaji K, Shimodozono Y, Morikawa N, et al. Safety analysis of liposomal amphotericin B in adult patients: anaemia, thrombocytopenia, nephrotoxicity, hepatotoxicity and hypokalaemia. Int J Antimicrob Agents. 2011;38(5):417\u201320.","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"1189_CR16","doi-asserted-by":"publisher","first-page":"e01692","DOI":"10.1128\/aac.01692-24","volume":"69","author":"GR Thompson","year":"2025","unstructured":"Thompson GR, Sani GM, Donnelley MA, Figueroa JK, Ciuffetelli R, Trigg K, et al. Liposomal amphotericin B and complement activation-related pseudoallergy (CARPA). Krysan DJ, curatore. Antimicrob Agents Chemother. 2025;69(3):e01692\u201324.","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"1189_CR17","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1080\/14740338.2021.1922667","volume":"20","author":"A Tragiannidis","year":"2021","unstructured":"Tragiannidis A, Gkampeta A, Vousvouki M, Vasileiou E, Groll AH. Antifungal agents and the kidney: pharmacokinetics, clinical nephrotoxicity, and interactions. Exp Opin Drug Saf. 2021;20(9):1061\u201374.","journal-title":"Exp Opin Drug Saf"},{"issue":"Supplement4","key":"1189_CR18","doi-asserted-by":"publisher","first-page":"S244","DOI":"10.1093\/cid\/ciz064","volume":"68","author":"J Adler-Moore","year":"2019","unstructured":"Adler-Moore J, Lewis RE, Br\u00fcggemann RJM, Rijnders BJA, Groll AH, Walsh TJ. Preclinical Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antifungal Activity of Liposomal Amphotericin B. Clin Infect Dis. 2019;68(Supplement4):S244\u201359.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"1189_CR19","doi-asserted-by":"publisher","first-page":"e13771","DOI":"10.1111\/myc.13771","volume":"67","author":"T Ueda","year":"2024","unstructured":"Ueda T, Nakajima K, Ichiki K, Ishikawa K, Yamada K, Tsuchida T, et al. Association between the hypokalaemia index based on area over the serum potassium concentration curve and occurrence of acute kidney injury in patients administered liposomal amphotericin B. Mycoses. 2024;67(7):e13771.","journal-title":"Mycoses"},{"issue":"6","key":"1189_CR20","doi-asserted-by":"publisher","first-page":"e2864","DOI":"10.1371\/journal.pntd.0002864","volume":"8","author":"U Marking","year":"2014","unstructured":"Marking U, Den Boer M, Das AK, Ahmed EM, Rollason V, Ahmed BN, et al. Hypokalaemia-Induced Rhabdomyolysis after Treatment of Post-Kala-azar Dermal Leishmaniasis (PKDL) with High-Dose AmBisome in Bangladesh\u2014A Case Report. Louzir H, curatore. PLoS Negl Trop Dis. 2014;8(6):e2864.","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"1189_CR21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.4103\/sja.SJA_543_18","volume":"13","author":"S Cuschieri","year":"2019","unstructured":"Cuschieri S. The STROBE guidelines. Saudi J Anaesth. 2019;13(5):31.","journal-title":"Saudi J Anaesth"},{"issue":"3","key":"1189_CR22","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1097\/ALN.0000000000004054","volume":"136","author":"M Di Nardo","year":"2022","unstructured":"Di Nardo M, Tikkanen J, Husain S, Singer LG, Cypel M, Ferguson ND, et al. Postoperative Management of Lung Transplant Recipients in the Intensive Care Unit. Anesthesiology. 2022;136(3):482\u201399.","journal-title":"Anesthesiology"},{"issue":"11","key":"1189_CR23","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.healun.2021.07.012","volume":"40","author":"N Marczin","year":"2021","unstructured":"Marczin N, De Waal EEC, Hopkins PMA, Mulligan MS, Simon A, Shaw AD, et al. International consensus recommendations for anesthetic and intensive care management of lung transplantation. An EACTAIC, SCA, ISHLT, ESOT, ESTS, and AST approved document. J Heart Lung Transplantation. 2021;40(11):1327\u201348.","journal-title":"J Heart Lung Transplantation"},{"key":"1189_CR24","unstructured":"European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters [Internet]. Version 12.0. 2022. Available from: http:\/\/www.eucast.org. [accessed 04.25]."},{"key":"1189_CR25","first-page":"1","volume":"2","author":"Kidney Disease","year":"2012","unstructured":"Kidney Disease. Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl. 2012;2:1\u2013138.","journal-title":"Kidney Int Suppl"},{"key":"1189_CR26","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE). https:\/\/dctd.cancer.gov\/research\/ctep-trials\/for-sites\/adverse-events\/ctcae-v5-5x7.pdf."},{"issue":"1","key":"1189_CR27","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3390\/jof10010080","volume":"10","author":"A Boscolo","year":"2024","unstructured":"Boscolo A, Cattelan A, Marinello S, Medici F, Pettenon G, Congedi S, et al. Fungal Infections and Colonization after Bilateral Lung Transplant: A Six-Year Single-Center Experience. J Fungi (Basel). 2024;10(1):80.","journal-title":"J Fungi (Basel)"},{"issue":"4","key":"1189_CR28","doi-asserted-by":"publisher","first-page":"34","DOI":"10.14797\/mdcvj.1122","volume":"18","author":"CM Zapata","year":"2022","unstructured":"Zapata CM, Ibrahim HN. Kidney Disease after Heart and Lung Transplantation. Methodist Debakey Cardiovasc J. 2022;18(4):34\u201340.","journal-title":"Methodist Debakey Cardiovasc J"},{"issue":"4","key":"1189_CR29","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1053\/j.ackd.2009.04.002","volume":"16","author":"PT Pham","year":"2009","unstructured":"Pham PT, Slavov C, Pham PC. Acute kidney injury after liver, heart, and lung transplants: dialysis modality, predictors of renal function recovery, and impact on survival. Adv Chronic Kidney Dis. 2009;16(4):256\u201367. https:\/\/doi.org\/10.1053\/j.ackd.2009.04.002.","journal-title":"Adv Chronic Kidney Dis"},{"issue":"10","key":"1189_CR30","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.3390\/jcm8101713","volume":"8","author":"P Lertjitbanjong","year":"2019","unstructured":"Lertjitbanjong P, Thongprayoon C, Cheungpasitporn W, O\u2019Corragain OA, Srivali N, Bathini T, et al. Acute Kidney Injury after Lung Transplantation: A Systematic Review and Meta-Analysis. JCM. 2019;8(10):1713.","journal-title":"JCM"},{"issue":"3","key":"1189_CR31","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.diagmicrobio.2013.04.001","volume":"76","author":"RL Wade","year":"2013","unstructured":"Wade RL, Chaudhari P, Natoli JL, Taylor RJ, Nathanson BH, Horn DL. Nephrotoxicity and other adverse events among inpatients receiving liposomal amphotericin B or amphotericin B lipid complex. Diagn Microbiol Infect Dis. 2013;76(3):361\u20137.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"8","key":"1189_CR32","doi-asserted-by":"publisher","first-page":"760","DOI":"10.3390\/antibiotics13080760","volume":"13","author":"I Sacanella","year":"2024","unstructured":"Sacanella I, Esteve-Pitarch E, Guevara-Chaux J, Berrueta J, Garc\u00eda-Mart\u00ednez A, G\u00f3mez J, et al. A Real-World Data Observational Analysis of the Impact of Liposomal Amphotericin B on Renal Function Using Machine Learning in Critically Ill Patients. Antibiotics. 2024;13(8):760.","journal-title":"Antibiotics"},{"issue":"2","key":"1189_CR33","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jiac.2020.10.005","volume":"27","author":"M Yoshida","year":"2021","unstructured":"Yoshida M, Tamura K, Masaoka T, Nakajo E. A real-world prospective observational study on the efficacy and safety of liposomal amphotericin B in 426 patients with persistent neutropenia and fever. J Infect Chemother. 2021;27(2):277\u201383.","journal-title":"J Infect Chemother"},{"issue":"5","key":"1189_CR34","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/S0149-2918(03)80125-X","volume":"25","author":"JP Barrett","year":"2003","unstructured":"Barrett JP, Vardulaki KA, Conlon C, Cooke J, Daza-Ramirez P, Evans EGV, et al. A systematic review of the antifungal effectiveness and tolerability of amphotericin B formulations. Clin Ther. 2003;25(5):1295\u2013320.","journal-title":"Clin Ther"},{"issue":"6","key":"1189_CR35","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1038\/ki.1992.229","volume":"41","author":"RA Zager","year":"1992","unstructured":"Zager RA, Bredl CR, Schimpf BA. Direct amphotericin B-mediated tubular toxicity: Assessments of selected cytoprotective agents. Kidney Int. 1992;41(6):1588\u201394.","journal-title":"Kidney Int"},{"issue":"5","key":"1189_CR36","doi-asserted-by":"publisher","first-page":"e233072","DOI":"10.1136\/bcr-2019-233072","volume":"13","author":"D Armstrong-James","year":"2020","unstructured":"Armstrong-James D, Koh M, Ostermann M, Cockwell P. Optimal management of acute kidney injury in critically ill patients with invasive fungal infections being treated with liposomal amphotericin B. BMJ Case Rep. 2020;13(5):e233072.","journal-title":"BMJ Case Rep"},{"issue":"2","key":"1189_CR37","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/myc.12283","volume":"58","author":"DR Falci","year":"2015","unstructured":"Falci DR, Da Rosa FB, Pasqualotto AC. Comparison of nephrotoxicity associated to different lipid formulations of amphotericin B: a real-life study. Mycoses. 2015;58(2):104\u201312.","journal-title":"Mycoses"},{"issue":"6","key":"1189_CR38","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1517\/14740338.2013.827168","volume":"12","author":"AS Loo","year":"2013","unstructured":"Loo AS, Muhsin SA, Walsh TJ. Toxicokinetic and mechanistic basis for the safety and tolerability of liposomal amphotericin B. Exp Opin Drug Saf. 2013;12(6):881\u201395.","journal-title":"Exp Opin Drug Saf"},{"key":"1189_CR39","first-page":"17","volume":"1","author":"I Kyriakidis","year":"2016","unstructured":"Kyriakidis I, Tragiannidis A, Munchen S, Groll AH. Clinical hepatotoxicity associated with antifungal agents. Exp Opin Drug Saf. 2016;1:17.","journal-title":"Exp Opin Drug Saf"},{"issue":"2","key":"1189_CR40","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3109\/23744235.2015.1100322","volume":"48","author":"A Perrella","year":"2016","unstructured":"Perrella A, Esposito C, Amato G, Perrella O, Migliaccio C, Pisaniello D, et al. Antifungal prophylaxis with liposomal amphotericin B and caspofungin in high-risk patients after liver transplantation: impact on fungal infections and immune system. Infect Dis. 2016;48(2):161\u20136.","journal-title":"Infect Dis"},{"issue":"1","key":"1189_CR41","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12981-024-00649-w","volume":"21","author":"Y Tan","year":"2024","unstructured":"Tan Y, Mo Y, Wu S, Tan M, Song S, Liu J, et al. Safety of different amphotericin B formulations among AIDS patients with invasive fungal disease: a retrospective observational study. AIDS Res Ther. 2024;21(1):66.","journal-title":"AIDS Res Ther"},{"key":"1189_CR42","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ejim.2021.10.035","volume":"97","author":"H Bj\u00f6rnsson","year":"2022","unstructured":"Bj\u00f6rnsson H, Bj\u00f6rnsson E. Drug-induced liver injury: Pathogenesis, epidemiology, clinical features, and practical management. Eur J Intern Med. 2022;97:26\u201331.","journal-title":"Eur J Intern Med"},{"issue":"2","key":"1189_CR43","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00253-005-1955-9","volume":"68","author":"A Lemke","year":"2005","unstructured":"Lemke A, Kiderlen AF, Kayser O, Amphotericin B. Appl Microbiol Biotechnol. 2005;68(2):151\u201362.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"2","key":"1189_CR44","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1128\/AAC.14.2.270","volume":"14","author":"RR MacGregor","year":"1978","unstructured":"MacGregor RR, Bennett JE, Erslev AJ. Erythropoietin Concentration in Amphotericin B-Induced Anemia. Antimicrob Agents Chemother. 1978;14(2):270\u20133.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3\u20134","key":"1189_CR45","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1159\/000233251","volume":"24","author":"H Mahmud","year":"2009","unstructured":"Mahmud H, Mauro D, Qadri SM, F\u00f6ller M, Lang F. Triggering of Suicidal Erythrocyte Death by Amphotericin B. Cell Physiol Biochem. 2009;24(3\u20134):263\u201370.","journal-title":"Cell Physiol Biochem"},{"key":"1189_CR46","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jconrel.2015.06.001","volume":"211","author":"G Jeswani","year":"2015","unstructured":"Jeswani G, Alexander A, Saraf S, Saraf S, Qureshi A. Ajazuddin. Recent approaches for reducing hemolytic activity of chemotherapeutic agents. J Controlled Release. 2015;211:10\u201321.","journal-title":"J Controlled Release"},{"issue":"10","key":"1189_CR47","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.3109\/10428194.2015.1010080","volume":"56","author":"DR Falci","year":"2015","unstructured":"Falci DR, Da Rosa FB, Pasqualotto AC. Hematological toxicities associated with amphotericin B formulations. Leuk Lymphoma. 2015;56(10):2889\u201394.","journal-title":"Leuk Lymphoma"},{"key":"1189_CR48","unstructured":"Maertens J, Herbrecht R, Fodil S, Voeght AD, Delavigne K, Liebregts T et al. Real-world dataset demonstrates favorable safety profile of Liposomal Amphotericin B for the treatment of invasive aspergillosis in high-risk haemato-oncology patients. 35th Congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) 2025;77(Supplement_2): ii11\u201320."},{"key":"1189_CR49","doi-asserted-by":"crossref","unstructured":"Viale PL, Mirandola S, Natalini C, Esposti LD, Dovizio M, Veronesi C et al. A retrospective Italian analysis on the characteristics of invasive fungal infections in the intensive care unit setting: CHARTER-IFI study. Mycoses. 2024;67(8):e13779.","DOI":"10.1111\/myc.13779"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40360-026-01189-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-026-01189-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-026-01189-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T11:36:26Z","timestamp":1789212986000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40360-026-01189-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,3]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1189"],"URL":"https:\/\/doi.org\/10.1186\/s40360-026-01189-x","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,3]]},"assertion":[{"value":"6 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"We confirm that all methods were carried out in accordance with relevant guidelines and regulations of the Helsinki declaration. Informed consent was obtained from all subjects. This study was approved by the Institutional Ethics Committee of Padua University Hospital (reference number: 6320\/AO\/25, 05\/15\/2025).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"125"}}